A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
NCT06174779 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 420
Last updated 2025-06-06
Summary
A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HM11260C in adult obesity patients without diabetes mellitus
Conditions
Interventions
- DRUG
-
HM11260C
Test drug
- DRUG
-
Placebo drug
Sponsors & Collaborators
-
Hanmi Pharmaceutical Company Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-03
- Primary Completion
- 2025-12-31
- Completion
- 2026-07-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients
NCT05197556 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
NCT06250946 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of S-309309 in Obese Adults
NCT05925114 ·Status: COMPLETED ·Phase: PHASE2
-
BMS-646256 in Obese and Overweight Type 2 Diabetics
NCT00541567 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
NCT06118021 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects
NCT00388609 ·Status: TERMINATED ·Phase: PHASE2
-
HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
NCT06520540 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
NCT06049329 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
NCT00959426 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112
NCT04732988 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
NCT01872182 ·Status: TERMINATED ·Phase: PHASE3
-
One-Year Study of S1B-509 vs Placebo for Weight Loss
NCT06517797 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
NCT06481098 ·Status: COMPLETED ·Phase: PHASE1
-
Phase Ib Clinical Study of HDM1005 Injection
NCT06637020 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of [14C] GZR18
NCT07119450 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
NCT06350812 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT04144049 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing
NCT06820476 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
NCT00799006 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients
NCT00239174 ·Status: COMPLETED ·Phase: PHASE2
-
Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
NCT04167553 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HRS9531 Tablet in Obese Subjects
NCT06841445 ·Status: COMPLETED ·Phase: PHASE2